ERBB2 and neoplasm: There were no significant differences in age, obesity, hormonal status, histology, histopathological grade, Ki67, AR expression, positive lymph node involvement, tumor subtype (TN or HER2+) or chemotherapy regimen received between positive and negative ALDH1A1 expression.